Long-term follow-up of patients with SCA who underwent penile aspiration and epinephrine irrigation for prolonged priapism
| Patient . | Follow-up* (months) . | Current Treatment . | Outcome . |
|---|---|---|---|
| 1 | 40 | Monthly IM leuprolide | Normal potency |
| 2 | Lost to follow-up | ||
| 3 | 58 | Oral pseudoephedrine prn | Normal potency |
| 4 | 41 | None | Normal potency |
| 5 | 48 | Monthly IM leuprolide | Normal potency |
| 6 | 51 | None | Normal potency |
| 7 | Lost to follow-up | ||
| 8 | 3 | Oral pseudoephedrine prn | Normal potency |
| 9 | 39 | Oral pseudoephedrine prn | Normal potency |
| 10 | 46 | Deceased | |
| 11 | 12 | Scheduled oral pseudoephedrine | Normal potency |
| 12 | 34 | Oral pseudoephedrine prn | Normal potency |
| 13 | 20 | Oral pseudoephedrine prn | Normal potency |
| 14 | 40 | Oral pseudoephedrine prn | Residual penile fibrosis |
| 15 | 48 | Monthly IM leuprolide | Normal potency |
| Patient . | Follow-up* (months) . | Current Treatment . | Outcome . |
|---|---|---|---|
| 1 | 40 | Monthly IM leuprolide | Normal potency |
| 2 | Lost to follow-up | ||
| 3 | 58 | Oral pseudoephedrine prn | Normal potency |
| 4 | 41 | None | Normal potency |
| 5 | 48 | Monthly IM leuprolide | Normal potency |
| 6 | 51 | None | Normal potency |
| 7 | Lost to follow-up | ||
| 8 | 3 | Oral pseudoephedrine prn | Normal potency |
| 9 | 39 | Oral pseudoephedrine prn | Normal potency |
| 10 | 46 | Deceased | |
| 11 | 12 | Scheduled oral pseudoephedrine | Normal potency |
| 12 | 34 | Oral pseudoephedrine prn | Normal potency |
| 13 | 20 | Oral pseudoephedrine prn | Normal potency |
| 14 | 40 | Oral pseudoephedrine prn | Residual penile fibrosis |
| 15 | 48 | Monthly IM leuprolide | Normal potency |
The duration of follow-up is from the last aspiration and irrigation procedure until February 28, 1999.